Mediocarb 150mg Injection Substitute
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
CARBOPLATIN-150MG
Uses:
Ovarian cancer and Small cell lung cancer
Medicinal Benefits:
Mediocarb 150mg Injection contains 'Carboplatin' which belongs to a group of anti-cancer medicines used to treat ovarian cancer and small cell lung cancer. It works by damaging the genetic material (DNA) of the cancer cells, which stops their growth and multiplication. It can be used alone or with other chemotherapy drugs depending on your cancer type.
Mediocarb 150mg Injection contains 'Carboplatin'. Carboplatin works by breaching the cellular wall and binding to the cell’s DNA, preventing the cell from dividing and functioning normally, which eventually kills the cell.
Yes, Mediocarb 150mg Injection can cause low neutrophils levels, a type of white blood cells that help fight infections. If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or believe you have an infection.
Mediocarb 150mg Injection should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents.
Before you receive treatment with Mediocarb 150mg Injection, tell your doctor about all of your medical conditions. You should not receive Mediocarb 150mg Injection if you are allergic to carboplatin or any contents in Mediocarb 150mg Injection. It should not be employed in patients with severe bone marrow depression or significant bleeding.
If not given an inappropriate dose, Mediocarb 150mg Injection can cause toxic effects, although not everyone gets it. So, Mediocarb 150mg Injection is prescribed by a doctor experienced in the use of medications to treat cancer only.
Avoid taking Mediocarb 150mg Injection if you are pregnant because Mediocarb 150mg Injection can cause harmful effects on the unborn baby. Females should follow effective birth control methods during treatment and at least six months after the final dose of Mediocarb 150mg Injection.